Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andrew L Freeman

The Ephrin-A1 Ligand and Its Receptor, EphA2, Are Expressed During Tumor Neovascularization

Oncogene

English

Related publications

Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase

Journal of Biological Chemistry

English

Retraction: The Chemokine Receptor CXCR6 and Its Ligand CXCL16 Are Expressed in Carcinomas and Inhibit Proliferation

Cancer Research

Oncology

2011

English

Faculty Opinions Recommendation of the Ephrin-A1/Epha2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

2016

English

361 Ephrin-A1 Ligand Strengthens Tight Junction Function and Prevents Th2 Cytokine-Induced Barrier Collapse

Journal of Investigative Dermatology

English

Structural and Functional Studies of the Effects of Phosphorylation on Ephrin Receptor Tyrosine Kinase, EphA2, Receptor Intracellular Domains and the Relationship With Its Sam Domain as an Autoinhibitor

Biophysical Journal

Biophysics

2019

English

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

Journal of Investigative Dermatology

English

Functional and Ultrastructural Analysis of Annexin A1 and Its Receptor in Extravasating Neutrophils During Acute Inflammation

American Journal of Pathology

Forensic Medicine

Pathology

2009

English

Identification of a Novel Activation-Inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand

Journal of Biological Chemistry

English

The Neurotrophic Receptor Ntrk2 Directs Lymphoid Tissue Neovascularization During Leishmania Donovani Infection

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Andrew L Freeman

The Ephrin-A1 Ligand and Its Receptor, EphA2, Are Expressed During Tumor Neovascularization

Related publications

Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase

Retraction: The Chemokine Receptor CXCR6 and Its Ligand CXCL16 Are Expressed in Carcinomas and Inhibit Proliferation

Faculty Opinions Recommendation of the Ephrin-A1/Epha2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

361 Ephrin-A1 Ligand Strengthens Tight Junction Function and Prevents Th2 Cytokine-Induced Barrier Collapse

Structural and Functional Studies of the Effects of Phosphorylation on Ephrin Receptor Tyrosine Kinase, EphA2, Receptor Intracellular Domains and the Relationship With Its Sam Domain as an Autoinhibitor

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

Functional and Ultrastructural Analysis of Annexin A1 and Its Receptor in Extravasating Neutrophils During Acute Inflammation

Identification of a Novel Activation-Inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand

The Neurotrophic Receptor Ntrk2 Directs Lymphoid Tissue Neovascularization During Leishmania Donovani Infection